Etiology of hypercoagulable state in women with recurrent fetal loss without other causes of miscarriage from Southern Italy: New clinical target for antithrombotic therapy

Biologics: Targets and Therapy

Volumn 2, Issue 4, 2008, Pages 897-902

  D'Uva, Maristella ^a   di Micco, Pierpaolo ^b   Strina, Ida ^a   Ranieri, Antonio ^a   Alviggi, Carlo ^a   Mollo, Antonio ^a   Fabozzi, Francesca ^a   Cacciapuoti, Lucia ^a   di Frega, Maria Teresa Scotto ^a   Iannuzzo, Mariateresa ^b   de Placido, Giuseppe ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NICU Buon Consiglio Fatebenefratelli Hospital of Naples   (Italy)

Author keywords

Antithrombotic drugs; Factor V Leiden; Hypercoagulable state; Hyperhomocysteinemia; Late pregnancy loss; Prothrombin; Recurrent pregnancy loss; Thrombophilia

Indexed keywords

EID: 75749107641     PISSN: 11775475     EISSN: 11775491     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Andersson A, Hultberg B, Brattstrom L, et al. 1992. Decreased serum homocysteine in pregnancy. Eur J Clin Chem Biochem, 30:377-9.
2. Asherson RA, Cervera R. 1994. "Primary", "secondary" and other variants of antiphospholipid syndrome. Lupus, 3:293-98.
3. Bonnette RE, Caudii MA, Boddie AM, et al. 1998. Plasma homocyst(e)ine concentrantions in pregnant and non pregnant women with controlled folate intake. Obstet Gynecol, 92:167-70.
4. Braulke I, Priggmayer M, Melloh P, Hinney B, Kostering H, Gunther H. 1993. Factor XII (Hageman) deficiency in women with abitual abortion: new subpopulation of recurrent aborters? Fertil Steril, 53:98-101.
5. Brenner B, Hoffan R, Carp H, et al; for the LIVE-ENOX Investigators. 2005b. Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX Study. J Throm Haemost, 3:1-2.
6. Brenner B, Hoffman R, Carp H, et al. 2005a. Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study. J Thromb Haemost, 3:227-9.
7. Brenner B, Sarig G, Weiner Z, et al. 1999. Thrombophilic polymorphisms are common in women with fetal loss without apparent cause. Thromb Haemost, 82:6-9.
8. Carp H, Salomon O, Seidman D, et al. 2002. Prevalence of genetic markers for thrombophilia in recurrent pregnancy loss. Hum Reprod, 17:1633-7.
9. Chakrabarti S, Bhunia C, Bhattacharya DK. 1999. The prevalence of antiphospholipid antibodies in cases of recurrent pregnancy loss. JAPI, 47:496-8.
10. D'Uva M, Strina, I, Mollo A, et al. 2005. Acquired factor XII deficiency in a woman with recurrent pregnancy loss: working on a differential diagnosis in a single case. J Transl Med, 3:43.
11. Das I, Vasishta K, Dash S. 1991. Study of lupus anticoagulant in pregnant women with recurrent abortion. Aust N Z J Obstet Gynecol, 31:323-6.
12. Di Micco P, D'Uva M, Strina I, et al. 2004. The role of d-dimer as first marker of thrombophilia in women affected by sterility: implications in pathophysiology and diagnosis of thrombophilia-induced sterility. J Transl Med, 2:38.
13. Dossenbach-Glaninger A, von Trotsenburg M, Krugluger W, et al. 2004. Elevated coagulation factor VIII and the risk for maternal early pregnancy loss. Thromb Haemost, 91:694-9.
14. Fatini C, Gensini F, Battaglini B, Prisco D, Cellai AP, Fedi S. 2000. Angiotensin convertine enzyme DD genotype, angiotensin-receptor CC genotype, and hyperhomocysteinemia increase first-trimester fetal-loss susceptibility. Blood Coagul Fibrinolysis, 11:657-62.
15. Finan RR, Tamim H, Ameen G, et al. 2002. Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population. Am J Hematol, 71:300-5.
16. Grandone E, Margaglione M, Colaizzo D, et al. 1997. Factor V Leiden is associated with repeated and recurrent unexplained fetal losses. Thromb Haemost, 77:822-4.
17. Greer IA. 2003. Thrombophilia: implications for pregnancy outcome. Thromb Res, 2152:1-9.
18. 5). Thromb Haemost, 81:891-9.
19. Higashino M, Takakuwa K, Arakawa M, et al. 1998. Anticardiolipin antibody and anti-cardiolipin beta-2-glycoprotein I antibody in patients with recurrent fetal miscarriage. J Perinat Med, 26:384-9.
20. Infante-Rivard C, David M, Gauthier R, et al. 1991. Lupus anticoagulants, anticardiolipin antibodies, and fetal loss. A case-control study. N Eng J Med, 325:1063-9.
21. Ioannou HV, Mitsis M, Eleftjeriou A, et al. 2000. The prevalence of factor V Leiden as a risk factor for venous thromboembolism in the population of North-Western Greece. Int Angiol, 19:314-18.
22. Jones DW, Mackie IJ, Gallimore MJ, et al. 2001. Antibodies to factor XII and recurrent fetal loss in patients with the anti-antiphospholid syndrome. Br J Haematol, 113:550-2.
23. Lissak A, Sharon A, Fruchter O, et al. 1999. Polymorphism for mutation of cytosine to thymine at location 677 in the methylenetetrahydrofolate reductase gene is associated with recurrent early fetal loss. Am J Obstet Gynecol, 181:126-30.
24. Martinelli I, Taioli E, Cetin I, et al. 2000. Mutations in coagulation factors in women with unexplained late fetal loss. N Engl J Med, 343:1015-8.
25. Nelen WLDM, van der Molen EF, Blom HJ, et al. 1997. Recurrent early pregnancy loss and genetic-related distrubances in folate and homocysteine metabolism. Br J Hosp Med, 58:511-3.
26. Noble LS, Kutteh WH, Lashey N, et al. 2005. Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low molecular weight heparin versus unfractioned heparin. Fertil Steril, 83:684-90.
27. Pabinger I, Nemes L, Rintelen C, et al. 2000. Pregnancy associated risk for venous thromboembolism and pregnancy outcome in women homozygous for factor V Leiden. Hematol J, 1:37-41.
28. Pickering W, Marriott K, Regan L. 2001. G20210A prothrombin gene mutation: prevalence in a recurrent miscarriage population. Clin Appl Thromb Haemost, 7:25-8.
29. Pihusch R, Buchholz T, Lohse P, et al. 2001. Thrombophilic gene mutations and recurrent spontaneous abortion: prothrombin mutation increases the risk in the first trimester. Am J Reprod Immunol, 46:124-31.
30. Rai R, Shlebak A, Cohen H, et al. 2001. Factor V Leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriage. Hum Reprod, 16:961-5.
31. Reznikoff-Etievan MF, Cayol, V, Carbonne B, et al. 2001. Factor V Leiden and G20210A prothrombin mutations are risk factors for very early recurrent miscarriage. BJOG, 108:1251-4.
32. Robertson L, Wu O, Langhorne P, et al. 2006. The Thrombosis: risk and assessment of thrombophilia screening (TREATS) study. Thrombophilia in pregnancy: a systematic review. Br J Haematol, 132:171-96.
33. Rosendaal FR, Doggen CJ, Zivelin A, et al. 1998. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost, 79:706-8.
34. Rozen R. 2001. Polymorphisms of folate and cobalamine metabolism. In Homocysteine in Health and Disease Edited by Ralph Carmel and Donal W Jacobsen. Cambridge: Cambridge University Press. p. 259-69.
35. Sanson BJ, Fierich PW, Simioni P, et al. 1996. The risk of abortion and stillbirth in antithrombin-, protein C, and protein S deficient women. Thromb Haemost, 75:387-8.
36. Sarig G, Younis JS, Hoffman R, et al. 2002. Thrombophilia is common in women with idiopathic pregnancy loss and is associated with late pregnancy wastage. Fertil Steril, 77:342-7.
37. Smithells RW, Sheppard S, Schorah CJ, et al. 1980. Possible prevention of neural tube defects by periconceptional vitamin supplementation. Lancet, 8164:339-40.
38. Sotiriadis A, Vartholomatos G, Pavlou M, et al. 2007. Combined thrombophilic mutations in women with unexplained recurrent miscarriage. Am J Reprod Immunol, 57:133-41.
39. Stephenson MD, Ballem PJ, Tsang P, et al. 2004. Treatment of antiphospholipid syndrome (APS) in pregnancy: a randomised pilot trial comparing low molecular weight heparin to unfractioned heparin. J Obstet Gynaecol Can, 26:729-34.
40. Wouters MG, Boers GH, Blom HJ, et al. 1993. Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss. Fertil Steril, 60:820-5.
41. Younis JS, Brenner B, Ohel G, et al. 2000. Activated protein C resistance and factor V Leiden mutation can be associated with first-as well as secondtrimester recurrent pregnancy loss. Am J Reprod Immunol, 43:31-5.
42. Zalavras ChG, Giotopoulou S, Dokou E, et al. 2003. Prevalence of the G20210A prothrombin gene mutation in Northwestern Greece and association with venous thromboembolism. Int Angiol, 22:55-7.